Cardiolyse

📍 Helsinki, Finland🗓 Founded 2015👥 13 employees💰 Last funded Oct 2021
Cardiolyse is a cloud ECG & HRV analytics platform, that enables real-time remote heart health monitoring, providing plain personalized reports, detection and up to two months data-based prognosis on dangerous heart events. Our groundbreaking ECG analytic technology enables people 45+, their families, healthcare providers and insurance companies: - To get in-depth snapshot of cardiovascular system state and to monitor its trend; - Allows making six-month forecast of serious cardiovascular events; - To learn how current lifestyle is interconnected with heart conditions.
6
Total investors
2
Early stage
2
Mid stage
2
Late stage
2015
Founded
Investor geography5 countries
Germany
2
United Kingdom
1
Latvia
1
Italy
1
United Arab Emirates
1
Investor activity2016–2021 · investors recorded per year
20161201712019220212
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Cardiolyse?
Cardiolyse has 6 investors on record on gritt.io, including 2 early-stage backers, 2 mid-stage and 2 late-stage investors.
When did Cardiolyse last raise funding?
The most recent investment in Cardiolyse recorded on gritt.io was in October 2021.
When was Cardiolyse founded?
Cardiolyse was founded in 2015.
What industry is Cardiolyse in?
Cardiolyse operates in Wellness and Fitness Services. Find similar Wellness and Fitness Services investors on gritt.io.
Where is Cardiolyse based?
Cardiolyse is headquartered in Helsinki, Finland.